SCHEMBL12309343

SCHEMBL12309343

Cc1ccc(S(=O)(=O)N2CC3(C)CC2CC(C)(C)C3)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.55
▸ LMNA P02545 4/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ GAA P10253 4/20 0.54
▸ HPGD P15428 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ RAB9A P51151 3/20 0.43
▸ GALR3 O60755 2/20 0.43
▸ HSD11B1 P28845 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ AVPR2 P30518 3/20 0.39
▸ AVPR1A P37288 3/20 0.39
▸ TRPV4 Q9HBA0 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12309384 0.91 ALDH1A1 (0.55) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL12309247 0.89 ALDH1A1 (0.56) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL2463969 0.85 ALDH1A1 (0.57) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL12309350 0.84 ALDH1A1 (0.51) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL12309258 0.84 ALDH1A1 (0.51) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL12309234 0.84 ALDH1A1 (0.58) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL2458098 0.82 ALDH1A1 (0.56) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL12309291 0.81 ALDH1A1 (0.57) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL12309237 0.80 ALDH1A1 (0.78) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL2462776 0.80 ALDH1A1 (0.58) ALDH1A1LMNAKMT2AHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466149-B2 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I MERCK SHARP & DOHME CORP. (US) 2013-06-18 — — US disclosed
US-20110237559-A1 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 SCHERING CORPORATION (US) 2011-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237559-A1 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 HSD17B1, HSD11B1, HSD17B11 ALDH1A1 29/4885LMNA 3130/4885KMT2A 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback